Z
Zetta Genomics
The Genome Optimised Data Store: Enabling healthcare transformation using big data technology
About Zetta Genomics
Zetta Genomics is a pioneering company in the field of genomic data, spun out from the University of Cambridge and Genomics England. The company specializes in providing advanced genomic data solutions that enhance predictive medicine. Their core product, XetaBase, is designed to manage and analyze vast amounts of genomic data, helping clinicians and researchers find critical genetic variations efficiently. Zetta Genomics primarily serves healthcare providers, research institutions, and clinical genetics services. Operating in the rapidly growing genomics market, the company employs a subscription-based business model, generating revenue through licensing its technology and offering data management services. The company is committed to making genomic data analysis more accessible and user-friendly, thereby accelerating the adoption of predictive medicine.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- Cambridge, United Kingdom
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Nina Capital
APEX Ventures
Cambridge Enterprise
We Venture Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Zetta Genomics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zetta Genomics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.